Jani P, Halbert G W, Langridge J, Florence A T
School of Pharmacy, University of London, UK.
J Pharm Pharmacol. 1990 Dec;42(12):821-6. doi: 10.1111/j.2042-7158.1990.tb07033.x.
Polystyrene microspheres in the size range 50 nm to 3 microns were fed by gavage to female Sprague Dawley rats daily for 10 days at a dose of 1.25 mg/kg-1. Previous histological evidence of the uptake of these particles and their absorption across the gastrointestinal tract and passage via the mesentery lymph supply and lymph nodes to the liver and spleen was confirmed by analysis of tissues for the presence of polystyrene by gel permeation chromatography. Measurement of radioactivity of tissues following administration of 100 nm and 1 micron I125-labelled polystyrene latex particles for 8 days was corroborative although less secure because of the potential lability of the labelled particles. The extent of absorption of 50 nm particles under the conditions of these experiments was 34% and of the 100 nm particles 26% (as measured by determination of polystyrene content), of which total, about 7% (50 nm) and 4% (100 nm), was in the liver, spleen, blood and bone marrow. Particles larger than 100 nm did not reach the bone marrow, and those larger than 300 nm were absent from blood. No particles were detected in heart or lung tissue.
将粒径范围为50纳米至3微米的聚苯乙烯微球每日经口灌胃给予雌性斯普拉格-道利大鼠,持续10天,剂量为1.25毫克/千克。先前关于这些颗粒的摄取、经胃肠道吸收以及通过肠系膜淋巴供应和淋巴结进入肝脏和脾脏的组织学证据,通过凝胶渗透色谱法分析组织中聚苯乙烯的存在得到了证实。给予100纳米和1微米碘125标记的聚苯乙烯乳胶颗粒8天后,对组织放射性的测量提供了佐证,不过由于标记颗粒可能不稳定,证据不太确凿。在这些实验条件下,50纳米颗粒的吸收程度为34%,100纳米颗粒为26%(通过测定聚苯乙烯含量),其中总计约7%(50纳米)和4%(100纳米)存在于肝脏、脾脏、血液和骨髓中。大于100纳米的颗粒未到达骨髓,大于300纳米的颗粒在血液中未出现。在心脏或肺组织中未检测到颗粒。